Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Bio-Rad Laboratories Inc (BIO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Bio-Rad Labs's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
275.03 -3.18    -1.14%
13:09:05 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 76,071
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 272.45 - 277.30
Bio-Rad Labs 275.03 -3.18 -1.14%

BIO Balance Sheet

 
Featured here, the Balance Sheet for Bio-Rad Laboratories Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 3048.33 3146.77 3138.87 3277.25
Cash and Short Term Investments 1607.14 1758.99 1722.69 1851.45
Cash - - - -
Cash & Equivalents 403.82 457.85 390 464.14
Short Term Investments 1203.33 1301.14 1332.68 1387.32
Total Receivables, Net 500.92 468.6 500.68 513.07
Accounts Receivables - Trade, Net 489.02 457.4 491.58 498.27
Total Inventory 780.52 775.82 776.6 752.94
Prepaid Expenses 140.04 123.91 122.64 120.84
Other Current Assets, Total 19.71 19.45 16.26 38.95
Total Assets 12299.07 11895.94 11978.23 13667.41
Property/Plant/Equipment, Total - Net 723.74 711.4 687.94 680.55
Property/Plant/Equipment, Total - Gross 1790.44 1738.56 1749 1718.08
Accumulated Depreciation, Total -1066.7 -1027.16 -1061.06 -1037.53
Goodwill, Net 413.57 406.95 411.52 407.76
Intangibles, Net 320.51 314.19 328.71 327.83
Long Term Investments 7696.57 7216.86 7309.74 8877.11
Note Receivable - Long Term 11.9 11.2 9.1 14.8
Other Long Term Assets, Total 96.35 99.77 101.46 96.91
Other Assets, Total 1502.64 1627.81 1624.87 1666.13
Total Current Liabilities 522.8 558.18 581.98 589.62
Accounts Payable 144.62 111.86 149.54 160.98
Payable/Accrued - - - -
Accrued Expenses 139.93 154.95 154.7 173.91
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 40.86 39.59 37.02 36.67
Other Current liabilities, Total 197.38 251.78 240.72 218.06
Total Liabilities 3557.94 3479.74 3531.34 3903.7
Total Long Term Debt 1199.05 1198.71 1198.38 1198
Long Term Debt 1189.44 1188.99 1188.46 1188.02
Capital Lease Obligations 9.61 9.72 9.92 9.98
Deferred Income Tax 1475.5 1369.56 1401.83 1769.78
Minority Interest - - - -
Other Liabilities, Total 360.59 353.3 349.14 346.29
Total Equity 8741.13 8416.2 8446.89 9763.72
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.003 0.003 0.003 0.003
Additional Paid-In Capital 449.08 439.46 473.87 463.4
Retained Earnings (Accumulated Deficit) 9260.63 8910.92 8804.66 9966.96
Treasury Stock - Common -632.54 -436.62 -458.78 -258.3
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -336.04 -497.56 -372.86 -408.35
Total Liabilities & Shareholders' Equity 12299.07 11895.94 11978.23 13667.41
Total Common Shares Outstanding 28.79 29.1 29.36 29.6
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BIO Comments

Write your thoughts about Bio-Rad Laboratories Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Petet Larkar
Petet Larkar May 05, 2023 1:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
340 first
Petet Larkar
Petet Larkar May 05, 2023 1:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
250 next
Baby Coin
Baby Coin Jan 29, 2023 4:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
🚀 vs ⬇️ ?
Jack Mah
Jack Mah Jan 29, 2023 4:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
🚀🚀🚀🚀🚀
Wolf Street
Wolf Street Jan 29, 2023 4:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
🚀
Nov 10, 2022 12:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I don't know the company, just came to say: That's the name of a company that could start a zombie apocalypse.
Ryan Andrew
Ryan Andrew Jul 18, 2022 9:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why?
Makoto Kondo
Makoto Kondo Aug 09, 2021 10:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Going to drop by shrinking rev and eps
Makoto Kondo
Makoto Kondo Apr 29, 2021 4:58PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sold before the crazy beat..
Exchange Watchdog
Exchange Watchdog Mar 11, 2021 1:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Massively undervalued!
Duane Goodson
Duane Goodson Jan 04, 2021 11:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
RDGL 0.125 By 1/16/2021 FDA will provide a final decision to grant or deny their request for breakthrough designation.
JB VK
JB VK Oct 30, 2020 10:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Incredible earnings! Come on in now
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email